Global Active Pharmaceutical Ingredient (API) Market Size, Status, Research and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 103

Report ID: 3085

The Active Pharmaceutical Ingredient (API) is the part of any drug that produces its effects. Some drugs, such as combination therapies, have multiple active ingredients to treat different symptoms or act in different ways.
In 2018, the global Active Pharmaceutical Ingredient (API) market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Active Pharmaceutical Ingredient (API) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Active Pharmaceutical Ingredient (API) development in United States, Europe and China.

The key players covered in this study
Teva
Sun Pharmaceutical
Aurobindo Pharma
Albemarle
Sigma-Aldrich
Mylan
Allergan
...

Market segment by Type, the product can be split into
Innovative APIS Segment
Generic APIS Segment

Market segment by Application, split into
Oncology
Diabetes
Cardiovascular Disease
Cns and Neurological Disorders
Orthopedic Disorders
Nephrology
Ophthalmology
Pulmonology
Gastrointestinal Disorders
Endocrinology

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Active Pharmaceutical Ingredient (API) status, future forecast, growth opportunity, key market and key players.
To present the Active Pharmaceutical Ingredient (API) development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Active Pharmaceutical Ingredient (API) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Active Pharmaceutical Ingredient (API) Market Size Growth Rate by Type (2014-2025)
1.4.2 Innovative APIS Segment
1.4.3 Generic APIS Segment
1.5 Market by Application
1.5.1 Global Active Pharmaceutical Ingredient (API) Market Share by Application (2014-2025)
1.5.2 Oncology
1.5.3 Diabetes
1.5.4 Cardiovascular Disease
1.5.5 Cns and Neurological Disorders
1.5.6 Orthopedic Disorders
1.5.7 Nephrology
1.5.8 Ophthalmology
1.5.9 Pulmonology
1.5.10 Gastrointestinal Disorders
1.5.11 Endocrinology
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Active Pharmaceutical Ingredient (API) Market Size
2.2 Active Pharmaceutical Ingredient (API) Growth Trends by Regions
2.2.1 Active Pharmaceutical Ingredient (API) Market Size by Regions (2014-2025)
2.2.2 Active Pharmaceutical Ingredient (API) Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Active Pharmaceutical Ingredient (API) Market Size by Manufacturers
3.1.1 Global Active Pharmaceutical Ingredient (API) Revenue by Manufacturers (2014-2019)
3.1.2 Global Active Pharmaceutical Ingredient (API) Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Active Pharmaceutical Ingredient (API) Market Concentration Ratio (CR5 and HHI)
3.2 Active Pharmaceutical Ingredient (API) Key Players Head office and Area Served
3.3 Key Players Active Pharmaceutical Ingredient (API) Product/Solution/Service
3.4 Date of Enter into Active Pharmaceutical Ingredient (API) Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Active Pharmaceutical Ingredient (API) Market Size by Type (2014-2019)
4.2 Global Active Pharmaceutical Ingredient (API) Market Size by Application (2014-2019)

5 United States
5.1 United States Active Pharmaceutical Ingredient (API) Market Size (2014-2019)
5.2 Active Pharmaceutical Ingredient (API) Key Players in United States
5.3 United States Active Pharmaceutical Ingredient (API) Market Size by Type
5.4 United States Active Pharmaceutical Ingredient (API) Market Size by Application

6 Europe
6.1 Europe Active Pharmaceutical Ingredient (API) Market Size (2014-2019)
6.2 Active Pharmaceutical Ingredient (API) Key Players in Europe
6.3 Europe Active Pharmaceutical Ingredient (API) Market Size by Type
6.4 Europe Active Pharmaceutical Ingredient (API) Market Size by Application

7 China
7.1 China Active Pharmaceutical Ingredient (API) Market Size (2014-2019)
7.2 Active Pharmaceutical Ingredient (API) Key Players in China
7.3 China Active Pharmaceutical Ingredient (API) Market Size by Type
7.4 China Active Pharmaceutical Ingredient (API) Market Size by Application

8 Japan
8.1 Japan Active Pharmaceutical Ingredient (API) Market Size (2014-2019)
8.2 Active Pharmaceutical Ingredient (API) Key Players in Japan
8.3 Japan Active Pharmaceutical Ingredient (API) Market Size by Type
8.4 Japan Active Pharmaceutical Ingredient (API) Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Active Pharmaceutical Ingredient (API) Market Size (2014-2019)
9.2 Active Pharmaceutical Ingredient (API) Key Players in Southeast Asia
9.3 Southeast Asia Active Pharmaceutical Ingredient (API) Market Size by Type
9.4 Southeast Asia Active Pharmaceutical Ingredient (API) Market Size by Application

10 India
10.1 India Active Pharmaceutical Ingredient (API) Market Size (2014-2019)
10.2 Active Pharmaceutical Ingredient (API) Key Players in India
10.3 India Active Pharmaceutical Ingredient (API) Market Size by Type
10.4 India Active Pharmaceutical Ingredient (API) Market Size by Application

11 Central & South America
11.1 Central & South America Active Pharmaceutical Ingredient (API) Market Size (2014-2019)
11.2 Active Pharmaceutical Ingredient (API) Key Players in Central & South America
11.3 Central & South America Active Pharmaceutical Ingredient (API) Market Size by Type
11.4 Central & South America Active Pharmaceutical Ingredient (API) Market Size by Application

12 International Players Profiles
12.1 Teva
12.1.1 Teva Company Details
12.1.2 Company Description and Business Overview
12.1.3 Active Pharmaceutical Ingredient (API) Introduction
12.1.4 Teva Revenue in Active Pharmaceutical Ingredient (API) Business (2014-2019)
12.1.5 Teva Recent Development
12.2 Sun Pharmaceutical
12.2.1 Sun Pharmaceutical Company Details
12.2.2 Company Description and Business Overview
12.2.3 Active Pharmaceutical Ingredient (API) Introduction
12.2.4 Sun Pharmaceutical Revenue in Active Pharmaceutical Ingredient (API) Business (2014-2019)
12.2.5 Sun Pharmaceutical Recent Development
12.3 Aurobindo Pharma
12.3.1 Aurobindo Pharma Company Details
12.3.2 Company Description and Business Overview
12.3.3 Active Pharmaceutical Ingredient (API) Introduction
12.3.4 Aurobindo Pharma Revenue in Active Pharmaceutical Ingredient (API) Business (2014-2019)
12.3.5 Aurobindo Pharma Recent Development
12.4 Albemarle
12.4.1 Albemarle Company Details
12.4.2 Company Description and Business Overview
12.4.3 Active Pharmaceutical Ingredient (API) Introduction
12.4.4 Albemarle Revenue in Active Pharmaceutical Ingredient (API) Business (2014-2019)
12.4.5 Albemarle Recent Development
12.5 Sigma-Aldrich
12.5.1 Sigma-Aldrich Company Details
12.5.2 Company Description and Business Overview
12.5.3 Active Pharmaceutical Ingredient (API) Introduction
12.5.4 Sigma-Aldrich Revenue in Active Pharmaceutical Ingredient (API) Business (2014-2019)
12.5.5 Sigma-Aldrich Recent Development
12.6 Mylan
12.6.1 Mylan Company Details
12.6.2 Company Description and Business Overview
12.6.3 Active Pharmaceutical Ingredient (API) Introduction
12.6.4 Mylan Revenue in Active Pharmaceutical Ingredient (API) Business (2014-2019)
12.6.5 Mylan Recent Development
12.7 Allergan
12.7.1 Allergan Company Details
12.7.2 Company Description and Business Overview
12.7.3 Active Pharmaceutical Ingredient (API) Introduction
12.7.4 Allergan Revenue in Active Pharmaceutical Ingredient (API) Business (2014-2019)
12.7.5 Allergan Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details